MRCK34:BVMF
Merck BDR
95,05 R$
0,00%
(0,00) 1D
2 հոկ, 17:05:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRCK34...
Open
95,05 R$
High
95,05 R$
Low
93,37 R$
Mkt. cap
356,01 մլրդ
Avg. vol.
7,41 հզր
Volume
1,65 հզր
52-wk high
100,98 R$
52-wk low
54,17 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
Open
95,05 R$
High
95,05 R$
Low
93,37 R$
Mkt. cap
356,01 մլրդ
Avg. vol.
7,41 հզր
Volume
1,65 հզր
52-wk high
100,98 R$
52-wk low
54,17 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
News stories
From web sources and news partners
TIKR.com
·
1 օր առաջ
Merck Stock Is Up 61% in a Year. Is There Room Left to Run?
BizTimes - Milwaukee Business News
·
2 օր առաջ
Merck business unit opens R&D facility in Sheboygan Falls
The Globe and Mail
·
2 օր առաջ
RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR